150 related articles for article (PubMed ID: 12164297)
1. The detection of Mycobacterium leprae protein and carbohydrate antigens in skin and nerve from leprosy patients with type 1 (reversal) reactions.
Lockwood DN; Colston MJ; Khanolkar-Young SR
Am J Trop Med Hyg; 2002 Apr; 66(4):409-15. PubMed ID: 12164297
[TBL] [Abstract][Full Text] [Related]
2. Immunohistological analysis of in situ expression of mycobacterial antigens in skin lesions of leprosy patients across the histopathological spectrum. Association of Mycobacterial lipoarabinomannan (LAM) and Mycobacterium leprae phenolic glycolipid-I (PGL-I) with leprosy reactions.
Verhagen C; Faber W; Klatser P; Buffing A; Naafs B; Das P
Am J Pathol; 1999 Jun; 154(6):1793-804. PubMed ID: 10362804
[TBL] [Abstract][Full Text] [Related]
3. In situ demonstration of Mycobacterium leprae antigens in leprosy lesions using monoclonal antibodies.
Narayanan RB; Girdhar BK; Malaviya GN; Sengupta U
Immunol Lett; 1990 Jun; 24(3):179-83. PubMed ID: 2200752
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical detection of PGL-1, LAM, 30 kD and 65 kD antigens in leprosy infected paraffin preserved skin and nerve sections.
Van den Bos IC; Khanolkar-Young S; Das PK; Lockwood DN
Lepr Rev; 1999 Sep; 70(3):272-80. PubMed ID: 10603716
[TBL] [Abstract][Full Text] [Related]
5. Demonstration of mycobacterial antigens in nerve biopsies from leprosy patients using peroxidase-antiperoxidase immunoenzyme technique.
Mshana RN; Humber DP; Harboe M; Belehu A
Clin Immunol Immunopathol; 1983 Dec; 29(3):359-68. PubMed ID: 6416726
[TBL] [Abstract][Full Text] [Related]
6. Immunohistological localization of mycobacterial antigens within the peripheral nerves of treated leprosy patients and their significance to nerve damage in leprosy.
Shetty VP; Uplekar MW; Antia NH
Acta Neuropathol; 1994; 88(4):300-6. PubMed ID: 7839822
[TBL] [Abstract][Full Text] [Related]
7. Demonstration of Mycobacterium leprae antigen in nerves of tuberculoid leprosy.
Barros U; Shetty VP; Antia NH
Acta Neuropathol; 1987; 73(4):387-92. PubMed ID: 2441563
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for type-1 reactions in borderline leprosy patients.
Roche PW; Theuvenet WJ; Britton WJ
Lancet; 1991 Sep; 338(8768):654-7. PubMed ID: 1679473
[TBL] [Abstract][Full Text] [Related]
9. Anti-Mycobacterium leprae monoclonal antibodies cross-react with human skin: an alternative explanation for the immune responses in leprosy.
Naafs B; Kolk AH; Chin A Lien RA; Faber WR; Van Dijk G; Kuijper S; Stolz E; Van Joost T
J Invest Dermatol; 1990 May; 94(5):685-8. PubMed ID: 1691241
[TBL] [Abstract][Full Text] [Related]
10. Events surrounding the recognition of Mycobacterium leprae in nerves.
Ridley MJ; Waters MF; Ridley DS
Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):99-108. PubMed ID: 3549942
[TBL] [Abstract][Full Text] [Related]
11. Tumour necrosis factor-alpha (TNF-alpha) synthesis is associated with the skin and peripheral nerve pathology of leprosy reversal reactions.
Khanolkar-Young S; Rayment N; Brickell PM; Katz DR; Vinayakumar S; Colston MJ; Lockwood DN
Clin Exp Immunol; 1995 Feb; 99(2):196-202. PubMed ID: 7851011
[TBL] [Abstract][Full Text] [Related]
12. The response to chemotherapy of serum Mycobacterium leprae-specific antigen in multibacillary leprosy patients.
Roche PW; Britton WJ; Neupane KD; Failbus SS; Cho SN; Theuvenet WJ
Am J Trop Med Hyg; 1991 Jun; 44(6):702-8. PubMed ID: 1858971
[TBL] [Abstract][Full Text] [Related]
13. Demonstration of Mycobacterium leprae specific antigens in leprosy lesions using monoclonal antibodies.
Narayanan RB; Ramu G; Sinha S; Sengupta U; Malaviya GN; Desikan KV
Indian J Lepr; 1985; 57(2):258-64. PubMed ID: 2416852
[TBL] [Abstract][Full Text] [Related]
14. Reactions in leprosy.
Bjune G
Lepr Rev; 1983 Jun; Spec No():61-7. PubMed ID: 6224993
[No Abstract] [Full Text] [Related]
15. Novel mechanisms in the immunopathogenesis of leprosy nerve damage: the role of Schwann cells, T cells and Mycobacterium leprae.
Spierings E; De Boer T; Zulianello L; Ottenhoff TH
Immunol Cell Biol; 2000 Aug; 78(4):349-55. PubMed ID: 10947859
[TBL] [Abstract][Full Text] [Related]
16. Persistence of Mycobacterium leprae in the peripheral nerve as compared to the skin of multidrug-treated leprosy patients.
Shetty VP; Suchitra K; Uplekar MW; Antia NH
Lepr Rev; 1992 Dec; 63(4):329-36. PubMed ID: 1479872
[TBL] [Abstract][Full Text] [Related]
17. In leprosy the presence of mycobacteria in the nerve is an essential factor in the cycle and spectrum of Mycobacterium leprae infection.
Negesse Y; Beimnet K; Miko T; Wondimus A; Berhan TY
Lepr Rev; 1993 Jun; 64(2):104-9. PubMed ID: 8341112
[TBL] [Abstract][Full Text] [Related]
18. Identification of Mycobacterium leprae antigens in tissues of leprosy patients using monoclonal antibodies.
Khanolkar SR; Mackenzie CD; Lucas SB; Hussen A; Girdhar BK; Katoch K; McAdam KP
Int J Lepr Other Mycobact Dis; 1989 Sep; 57(3):652-8. PubMed ID: 2674303
[TBL] [Abstract][Full Text] [Related]
19. Mycobacterium leprae-specific, HLA class II-restricted killing of human Schwann cells by CD4+ Th1 cells: a novel immunopathogenic mechanism of nerve damage in leprosy.
Spierings E; de Boer T; Wieles B; Adams LB; Marani E; Ottenhoff TH
J Immunol; 2001 May; 166(10):5883-8. PubMed ID: 11342602
[TBL] [Abstract][Full Text] [Related]
20. [The identification of the antigenic determinants of Mycobacterium leprae passed through laboratory animals by using monoclonal antibodies].
Diachin MN; Iushchenko AA; Ibragimov ChD; Chernousova LN; Litvinov VI
Zh Mikrobiol Epidemiol Immunobiol; 1994; (1):73-6. PubMed ID: 7514328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
